A retrospective study of the use of ROX index to predict failure in patients receiving CPAP for COVID-19

A. Yousuf (Watford, United Kingdom), D. Gottlieb (Watford, United Kingdom), A. Aggarwal (Watford, United Kingdom), B. Peacock (Watford, United Kingdom), S. Konda (Watford, United Kingdom)

Source: Virtual Congress 2021 – Acute non-invasive respiratory therapies in COVID-19 and beyond
Session: Acute non-invasive respiratory therapies in COVID-19 and beyond
Session type: E-poster
Number: 1766

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Yousuf (Watford, United Kingdom), D. Gottlieb (Watford, United Kingdom), A. Aggarwal (Watford, United Kingdom), B. Peacock (Watford, United Kingdom), S. Konda (Watford, United Kingdom). A retrospective study of the use of ROX index to predict failure in patients receiving CPAP for COVID-19. 1766

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
CPAP therapy impact in OSA related symptoms – a prospective study
Source: Eur Respir J 2006; 28: Suppl. 50, 411s
Year: 2006

A retrospective study on the use of non-invasive positive pressure ventilation, in patients with acute type 2 respiratory failure in a respiratory therapy unit, in patients deemed not to be fit for resuscitation
Source: Annual Congress 2010 - Noninvasive ventilation in the acute patient: outcome and pathophysiology
Year: 2010


Late Breaking Abstract - A retrospective analysis of ROX score for predicting treatment failure and progression to invasive ventilation in COVID patients requiring enhanced respiratory support
Source: Virtual Congress 2021 – Respiratory failure in COVID19 and beyond
Year: 2021


Compliance to ventilatory treatment in a cohort of patients on home CPAP or NIV: analysis by diagnosis, treatment type, and comorbidities
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019

Benefits to partners of nasal CPAP therapy given to patients with OSAS: a prospective analysis
Source: Eur Respir J 2001; 18: Suppl. 33, 420s
Year: 2001

Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study
Source: Eur Respir J, 56 (4) 2001935; 10.1183/13993003.01935-2020
Year: 2020



Biomarker measurement in asthma patients receiving biologic therapy: a real-world retrospective study
Source: International Congress 2018 – Eosinophils in airway disease
Year: 2018




Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study
Source: ERJ Open Res, 7 (1) 00778-2020; 10.1183/23120541.00778-2020
Year: 2021



Tofacitinib versus standard of care treatment in patients with COVID-19 pneumonia and respiratory failure: a multicenter cohort study
Source: Virtual Congress 2021 – Acute COVID - 19
Year: 2021



Benefits of interferon-αcon-1 (IFN-αcon-1) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy. Results of a 12-month prospective case-controlled study
Source: Eur Respir J 2006; 28: Suppl. 50, 439s
Year: 2006

Noninvasive positive pressure ventilation (NPPV) in the treatment of acute respiratory failure in patients with morbid obesity: a prospective cohort study
Source: Eur Respir J 2004; 24: Suppl. 48, 313s
Year: 2004

Late Breaking Abstract - Continuous positive airway pressure (CPAP) as an intervention for acute hypoxia in not-for-escalation (NFE) COVID-19 pneumonia patients: a single-centre observational study with retrospective cohort analysis
Source: Virtual Congress 2020 – COVID-19 clinical studies
Year: 2020


A prospective observational study on long-term non invasive ventilation (L-T NIV) in COPD patients attending an inpatient pulmonary rehabilitation program (PRP)
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018


Are SABA-reliant asthma patients receiving adequate ICS therapy? A nationwide cohort study in Sweden (HERA)
Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies
Year: 2019


Multi-institutional prospective cohort study of prognostic factors in patients with idiopathic pulmonary fibrosis receiving long-term oxygen therapy.
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019


Prospective cohort study of patients complaining of high pressure with CPAP/APAP (PAP) who switch to bi-level PAP (VAuto) as second-line therapy: POP-IN study
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019

Domiciliary treatment with noninvasive ventilation in patients with severe COPD: a 4 year retrospective study
Source: Eur Respir J 2006; 28: Suppl. 50, 187s
Year: 2006

Effect of excluding ICU-admission on clinical outcomes in a randomized control trial studying the effect of corticosteroids in patients hospitalized with CAP
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012

Development of a new prognosis index (BODS) in patients with COPD:a prospective cohort study
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018

Predictors of failure of non-invasive ventilation in patients with respiratory failure; a prospective study
Source: Annual Congress 2012 - Application of noninvasive ventilation in non-obstructive patients
Year: 2012